Lopinavir

Vivian Hou Chu, MD

• Associate Professor
• Member in the Duke Clinical Research Institute

https://medicine.duke.edu/faculty/vivian-hou-chu-md

The duration of surgical anesthesia depends on the time that the tourniquet is inflated and not on the local anesthetic drug selected medications memory loss purchase lopinavir with mastercard. Technically medicine dosage chart buy lopinavir 250 mg with amex, a regional intravenous anesthesia block is easier and faster to perform than a brachial plexus block or lower extremity block and is readily applicable to all age groups symptoms herpes discount 250 mg lopinavir with mastercard, including pediatric patients medicine recall 250 mg lopinavir purchase with mastercard. Can a supraclavicular block be performed successfully without the use of ultrasound How would you position the patient medications covered by medi cal order lopinavir 250 mg on line, anesthesia providers, monitors, and ultrasound machine in order to optimize performance of the block What features set them apart from other structures such as tendons, veins, and arteries What are the advantages and disadvantages of axillary versus interscalene block for this procedure What are the potential benefits of femoral nerve block for a patient undergoing knee surgery What type of surgery is most appropriate for an intravenous regional (Bier) block What precautions can be taken to minimize the risk of systemic toxicity with this block Infection related to ultrasound-guided single-injection peripheral nerve blockade: a decade of experience at Toronto Western hospital. Ultrasound guidance reduces the risk of local anesthetic systemic toxicity following peripheral nerve blockade. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine EvidenceBased Guidelines (Third Edition). Lipid emulsion infusion: resuscitation for local anesthetic and other drug overdose. Incidence of local anesthetic systemic toxicity and postoperative neurologic symptoms associated with 12,668 ultrasound-guided nerve blocks: an analysis from a prospective clinical registry. Wrong-site nerve blocks: 10 yr experience in a large multihospital healthcare system. Ultrasonographic guidance improves the success rate of interscalene brachial plexus blockade. An ultrasound study of the phrenic nerve in the posterior cervical triangle: implications for the interscalene brachial plexus block. The conjoint tendon of the latissimus dorsi and teres major: an important landmark for ultrasoundguided axillary block. Single-injection and continuous femoral nerve blocks are associated with different risks of falling. Continuous saphenous nerve block as supplement to single-dose local infiltration analgesia for postoperative pain management after total knee arthroplasty. Discharge readiness after tricompartment knee arthroplasty: adductor canal versus femoral continuous nerve blocks-a dual-center, randomized trial. Positioning injuries during surgery remain a significant source of perioperative morbidity. Anesthesia providers share a critical responsibility for the proper positioning of patients in the operating room. When a person reclines from an upright to a supine position, venous return to the heart increases and this increases preload, stroke volume, and cardiac output. These changes cause a brief increase in arterial blood pressure, which in turn activates afferent baroreceptors from the aorta (via the vagus nerve) and within the walls of the carotid sinuses (via the glossopharyngeal nerve) to decrease sympathetic outflow and to increase parasympathetic impulses to the sinoatrial node and myocardium. This parasympathetic outflow counters the increase in arterial blood pressure from increased preload and as a result systemic arterial blood pressure is maintained within a narrow range during postural changes in the nonanesthetized setting. Central, regional, and local physiologic responses are important in maintaining hemodynamics when changing positions during a normal day-to-day life. During various types of anesthesia some of these responses can the editors and publisher would like to thank Drs. Jae-Woo Lee and Lydia Cassorla for contributing to this chapter in the previous edition of this work. Pulmonary physiology is also altered by positional changes, which are further exaggerated during anesthesia. Furthermore, positioning that limits diaphragmatic movement pushes on the chest wall or abdomen, causing intrapulmonary shunting from atelectasis. Positioning also involves maintaining spine and extremity neutrality, proper padding, and securing the patient in order to prevent inadvertent changes in position. Patients often remain in the same position for long periods; therefore, prevention of positioning-related complications often requires compromise and judgment. During normal sleep we change positions, which prevents prolonged compression and excessive stretch. During anesthesia patients lose the ability to both sense injury and change position, increasing their risk for injury. The duration of more extreme positions, when necessary, should be limited as much as possible. Tissues overlying all bony prominences, such as the heels and sacrum, must be padded to prevent soft tissue ischemia due to pressure. Supine the supine position, also called the dorsal decubitus position, is the most common position for surgery. Arm abduction should be limited to less than 90 degrees in order to prevent brachial plexus injury from the head of the humerus pushing into the axilla. Hands and forearms are either supinated or kept in a neutral position with the palm toward the body to reduce external pressure on the ulnar nerve. When the arms are adducted, they are usually held alongside the body with a "draw sheet" that passes under the body and over the arm and is then tucked directly under the torso (not the mattress) to ensure that the arm remains properly placed next to the body. The anesthesia provider should pad all bony prominences as well as stopcocks or 322 Variations of the supine position are also frequently used such as the lawn-chair position, frog-leg position, and Trendelenburg positions. This modified supine position is often better tolerated by patients who are awake or undergoing monitored anesthesia care. The legs are placed slightly above the level of the heart, which facilitates venous drainage from the lower extremities. Furthermore, the xiphoid to pubic distance is decreased, reducing tension on the abdominal musculature. Typically the back of the bed is raised, the legs below the knees are lowered to an equivalent angle, and a slight Trendelenburg tilt is used to level the hips with the shoulders. The frog-leg position, in which the hips and knees are flexed and the hips are externally rotated with the soles of the feet facing each other, facilitates procedures to the perineum, medial thighs, genitalia, and rectum. The knees must be supported in order to minimize stress or dislocation of the hips. Tilting a supine patient head-down with the pubic symphysis as the highest part of the trunk is called the Trendelenburg position. It is named after a 19th century German surgeon who first described its use for abdominal surgery. Walter Cannon, a Harvard physiologist, is credited with popularizing the use of Trendelenburg positioning to improve hemodynamics for patients in hypovolemic shock during World War I. Trendelenburg positioning is commonly used today to increase venous return during hypotension, improve exposure during abdominal and laparoscopic surgery, and prevent air emboli during central line placement. Initially, placement of the patient head-down causes an autotransfusion from the legs with about a 9% from baseline increase in cardiac output in 1 minute. However, these changes are not sustained and within 10 minutes many hemodynamic variables, including cardiac output, return to baseline values. Nevertheless, Trendelenburg positioning is still part of the initial resuscitative efforts to treat hypovolemia. For patients receiving general anesthesia who will be placed in the Trendelenburg position, endotracheal intubation is strongly recommended over supraglottic airways because of the risk of pulmonary aspiration of gastric contents. Prolonged head-down position can lead to swelling of the face, conjunctivae, larynx, and tongue with an increased potential for postoperative upper airway obstruction. An air leak should be verified around the endotracheal tube or the larynx visualized prior to extubation. Nonsliding mattresses are recommended to prevent the patient from sliding cephalad. Caution should be exerted when shoulder braces are used because of considerable risk of compression or stretch injury to the brachial plexus. Patients in reverse Trendelenburg, particularly those patients who are hypovolemic, are at risk for hypotension due to decreased venous return. Complications Backache may occur in the supine position as the normal lumbar lordotic curvature is lost during general anesthesia with muscle relaxation or a neuraxial blockade. With obese patients, caution is advised when placing them in reverse axis on the operating room table (also see Chapter 29). The base of the operating room table is asymmetric, with the torso usually over the foot of the table. However, patients are often positioned with the torso over the open side of the table to improve surgical access or to permit use of equipment such as C-arm x-ray devices. The operating room table can tilt and tip over if sufficient weight is placed away from the base, particularly if extensions are used or the bed is tilted in the Trendelenburg position. Operating room table weight limits should be strictly observed; they differ substantially with regard to normal and reverse positioning. The legs are abducted 30 to 45 degrees from the midline, the knees are flexed, and legs are held by supports. Legs should be raised and lowered simultaneously in order to prevent spine torsion. The lower extremities should be padded to prevent compression against the leg rests. The common peroneal nerve wraps around the head of the fibula on the lateral leg and is at significant risk of injury if insufficiently padded. The foot section of the operating room table is lowered or taken away in order to facilitate the procedure. When the foot of the bed is raised again at the end of the procedure strict attention to the position of the hand must be paid to avoid a potentially disastrous crush injury to the fingers. For this reason, positioning the arms on armrests far from the table hinge point is recommended at all times when patients are in the lithotomy position. When the legs are elevated, preload increases, causing a transient increase in cardiac output. Again, the normal lordotic curvature of the lumbar spine is lost in this position, potentially aggravating any previous lower back pain. Lower extremity compartment syndrome is a rare but devastating complication associated with the lithotomy position. It occurs when perfusion to an extremity is inadequate because of either restricted arterial flow (from leg elevation) or obstructed venous outflow (direct limb compression or excessive hip flexion). This results in ischemia, edema, and rhabdomyolysis from increased tissue pressure within a fascial compartment. In a large retrospective review of 572,498 surgeries, the incidence of compartment syndromes was higher in the lithotomy (1 in 8720) and lateral decubitus (1 in 9711) positions as compared to the supine (1 in 92,441) position. Long surgical procedure time was the only distinguishing characteristic of the surgeries in which patients developed lower extremity compartment syndromes. Neurapraxia was the most common positioning-related complication (12 of 18 patients). Two patients from this cohort had compartment syndrome, and for both of these patients the time in high lithotomy exceeded 5 hours. Neither arm should be abducted more than 90 degrees in order to prevent injury to the brachial plexus from the humeral head. Additionally, an axillary roll should be placed underneath the patient just caudal to the axilla, not placed in the axilla itself. The axillary roll prevents compression injury to the dependent brachial plexus and dependent axillary vascular structures. Sometimes an axillary roll is not used if an inflatable beanbag is being used for positioning; however, the team must ensure that there is no compression in the axilla. With invasive arterial monitoring consider placing the catheter in the dependent arm in order to detect positioning compression of the axillary neurovascular structures. In a patient who is mechanically ventilated, the combination of the lateral weight of the mediastinum and disproportionate cephalad pressure of abdominal contents on the dependent diaphragm decreases compliance of the dependent lung and favors ventilation of the nondependent lung. Simultaneously pulmonary blood flow to the dependent lung increases because of the effect of gravity. This causes ventilation-perfusion mismatching and can affect alveolar ventilation and gas exchange. When general anesthesia is required in the prone position, endotracheal intubation, intravenous access, Foley catheter, and invasive hemodynamic access should all be obtained in the supine position first while the patient is still on a gurney. Make sure all lines and tubes are very well secured to prevent dislodgement during turning and to prevent tube migration during the case. Turning the patient from supine to prone requires coordination of all operating room providers. The anesthesia provider is primarily responsible for coordinating the move and for the repositioning of the head. An exception is in cases in which the head is placed in rigid pin fixation and the surgeon holds the pin frame. During the turn to prone, the head, neck, and spine are maintained in a neutral position. Some patients requiring prone positioning have unstable spines necessitating surgical operation. Also, strokes apparently can occur from presumed carotid 325 Lateral Decubitus In the lateral decubitus position the patient lies on the nonoperative side in order to facilitate surgery in the thorax, retroperitoneum, or hip. A pillow or other padding is generally placed between the knees with the dependent leg flexed to minimize excessive pressure on bony prominences and stretch of lower extremity nerves. Note flexion of the lower leg, padding between the legs, and proper support of both arms. The roll, in this case a bag of intravenous fluid, is placed well away from the axilla to prevent compression of the axillary artery and brachial plexus. For some cases when neuromonitoring will be used for the surgical procedure "pre-flip," baseline recordings are obtained prior to turning the patient prone for safety documentation. In order to minimize risk of dislodgement, disconnect as many monitors and lines as is safe and possible before turning the patient from supine to the prone position. This is particularly helpful for lines and monitors on the side that rotates the furthest (the outside arm). Our practice is to disconnect the endotracheal tube during movement and to reconnect immediately upon prone positioning. In most cases, the head is maintained in a neutral position using a surgical pillow, horseshoe headrest, or Mayfield rigid head pins. Several commercially available pillows are specially designed for the prone position. Most, including disposable foam versions, support the forehead, malar regions, and the chin with a cutout for the eyes, nose, and mouth.

Syndromes

• Constrictive pericarditis
• Prochlorperazine (Compazine)
• Physical activity
• Bleeding
• Is it the same on both sides?
• Urinary incontinence
• Tremor
• Problems breathing
• Bowel or bladder problems

Shih Introduction the question of whether an epileptic condition is likely to go into remission is arguably the single most important question patients have for their treating physicians medicine kit generic 250 mg lopinavir mastercard. When seizures go into remission there is a dramatic increase in quality of life (1 treatment uti lopinavir 250 mg mastercard, 2) and sense of well-being medicine that makes you throw up order discount lopinavir, as well as the opening up of avenues for employment and greater personal freedoms such as driving (3) medicine cabinets with mirrors buy 250 mg lopinavir with amex. Together with being side effect-free on seizure treatment medications given for migraines discount lopinavir 250 mg amex, seizure freedom constitutes one of the major goals of successful epilepsy management. However, it is important to note that this extensive literature is not homogenous. Methodologies differ, and research design varies greatly based on the specific questions asked. Many of the earlier studies on seizure remission rates were drawn from select populations seen at tertiary medical centres (4). Some more recent studies are retrospective¸ population-based, and derived from rural populations (5, 6), but may lack the rigorous data collection seen in earlier single centre studies. Studies also differ in terms of when their populations were evaluated vis-à-vis the disease and then remission process. Some studies specifically evaluated patients with newly diagnosed or untreated epilepsy; others recruited only patients who were deemed medically intractable and have failed at least several anticonvulsant medications. Patients with new-onset seizures represent a different epilepsy population than patients who have been refractory to multiple treatment approaches (7). Elderly patients suffering from post-stroke epilepsy have differing outcomes compared to children with familial epilepsies. Thus, in terms of clinical usefulness, any discussion on seizure remission needs to take into account patient demographics and the aetiology of the seizure disorder. Population-based studies have fairly consistently shown that 60­80% of patients diagnosed with a new-onset seizure disorder will achieve seizure remission in their lifetime (4, 8, 9). However, depending on the clinical history and epilepsy syndrome, individual patients can expect varying chances of seizure remission. In general, the idiopathic generalized epilepsies have a higher seizure remission rate than partial-onset epilepsy or symptomatic epilepsy (9­11). This chapter will review seizure remission rates by age group, epilepsy syndromes, and the specific clinical circumstance of medically refractory epilepsy. New-onset seizures By definition, epilepsy is diagnosed after a patient has two or more unprovoked seizures. Population-based studies place the general risk of a person developing epilepsy in her lifetime at 1­3% (12, 13). Prospective studies in the paediatric age group and general population of patients identified after a first unprovoked seizure estimate that about 25% will go on to have a second unprovoked seizure and be classified as epileptic (14, 15). A metaanalysis by Berg and Shinnar (16) of pre-1990 prospective observational studies found that on average, 60% of patients achieve remission as defined by seizure freedom for at least 2 years. In a longitudinal study of patients with epilepsy in Rochester, Minnesota, the probability of being in remission (at least 5 consecutive years seizure free, and continuing) at 20 years after diagnosis was 70% (4). In a prospective single-centre study of newly diagnosed and mostly untreated epilepsy patients, Kwan and Brodie found 63% achieved at least a 1-year seizure remission after anticonvulsant treatment (18). These studies have shown consistently similar results over the last several decades, despite advances in therapy and changes to the classification of seizures and epilepsy (19). This has led to a belief amongst many epileptologists that a majority of patients will achieve seizure remission regardless of the specific form of treatment. An interesting corollary to the question of epilepsy remission with treatment is the issue of spontaneous remission of seizures after a diagnosis of epilepsy is made. Because effective drug treatments have been in existence for almost 100 years, there are minimal data regarding the natural history of the untreated disease state. There are no prospective longitudinal studies of untreated epilepsy and the prospect of future studies of this kind is unlikely on ethical grounds. Of these 71 people, 31 (44%) were in seizure remission defined as seizure free for greater than 5 years. A retrospective Finnish study of 33 people with untreated epilepsy found a 2-year remission rate of 42% (20). It is important to point out that these studies suffer from methodological limitations which reduce the level of scientific confidence in the results. However, there is no doubt that a small population of persons with epilepsy, whether it be 10%, 20%, or higher, will achieve long-term spontaneous remission of their seizures. Age and remission rates the general perception is that seizures beginning in childhood are more likely to go into remission than seizures that start in adulthood, although evidence to that effect is sparse. Some of the earliest data on childhood epilepsy remission rates were derived from a population-based study in Nova Scotia which followed 504 children for an average of 7 years (21). Even though children with absence epilepsy and minor motor seizures were excluded from the analysis, 55% of the cohort was in remission at the end of the follow-up period. A prospective long-term population-based study in Finland followed 144 patients with seizure onset before age 16, an average of 37 years. At the end of follow-up, 67% of 144 patients were in terminal remission, on or off antiepileptic drugs (22). About one-third (31%) had remission from first treatment, while 50% of those in terminal remission did so with a mean delay of 9 years. In a 15-year Dutch follow-up study of patients diagnosed with childhood new-onset epilepsy, 5-year seizure remission was reached by 71% of the cohort (23). Age of onset between 5­9 years old was associated with a substantially increased remission rate. There are far fewer studies evaluating the natural history of adult-onset epilepsy. After treatment, 73% had at least a 2-year remission period at the end of 4 years. However, only 51 of the 106 patients remained seizure free at the termination of the study. One-year, 3-year, and 5-year seizure remission rates were 68%, 64%, and 58%, respectively. Thus, when one compares population-based studies of purely childhood epilepsy versus adult-onset epilepsy, there is no clear difference in seizure remission rate. The perception that childhood onset seizures have a higher remission rate likely stems from some studies with high numbers of patients diagnosed with childhood syndromes associated with excellent long-term prognosis. The groups of syndromes are: idiopathic focal epilepsies of infancy and childhood, familial (autosomal dominant) focal epilepsies, symptomatic (or probably symptomatic) focal epilepsies, idiopathic generalized epilepsies, reflex epilepsies, epileptic encephalopathies, progressive myoclonus epilepsies, and seizures not necessarily requiring a diagnosis of epilepsy. Many syndromes have been extensively studied, and outcome and prognosis data are available. The Dutch Study of Epilepsy in Childhood documented a remission rate of 75% in their eight subjects around the 15-year follow-up mark (23). Patients often have multiple absence seizures daily, but are developmentally and cognitively normal. Some studies defined remission as seizure freedom off anticonvulsant treatment for more than 1 year (29, 30). Others used terminal remission defined as seizure freedom for more than 1 year at the end of follow-up (31). The highest remission rate was found in the Dutch Study of Epilepsy in Childhood at 93 % being seizure free for greater than 1 year at the end of at least 12 years of follow-up (31). The authors also noted that 67% of the children were free of seizures for over 10 years at study termination. In a further subanalysis, the remission rate was 77% if the criterion of 1-year seizure remission off medication was applied. Their remission rate was 65%, and the development of generalized tonic­clonic seizures and myoclonic seizures were poor prognostic signs for remission. The myoclonus usually involves the neck, shoulders, arms, or legs with the upper extremities being more frequently affected. There is a strong genetic component with linkage to chromosomes 2, 3, 5, 6, and 15. However, five of the eight patients experienced a relapse during extended follow-up (11). Forty-three patients (86%) were seizure-free for over 1 year, but over half of this group experienced at least one relapse. Seizures may occasionally evolve to upper extremity clonic shaking or secondarily generalized tonic­clonic seizures. After a follow-up period of 12­17 years, 96% had a terminal remission greater than 5 years and 89% greater than 10 years. Remission rate in medically refractory epilepsy Epileptologists have long recognized that a subpopulation of persons with epilepsy continues to have recurrent seizures despite multiple medication trials. Terms that have been used to describe these patients include chronic epilepsy, pharmacoresistant, medication resistant, medically intractable, and medically refractory. The current definition of medically refractory epilepsy that is accepted by most epileptologists encompasses: (1) failure to achieve seizure freedom after at least two appropriate medication trials, (2) at least one seizure per month for at least the past 3 months. The Glasgow study gave us an indication that seizure remission rates diminished significantly after two medication trials (18). While 47% of the initial Glasgow cohort became seizure free with the first medication tried and an additional 13% went into seizure remission with the second drug, only 4% became seizure free with further medication trials. Callaghan and colleagues identified 246 patients in a single medical centre with medically refractory epilepsy in 2003 and prospectively followed them for up to 7 years (46, 47). The 12-month seizure remission rate was 5% per year, but 71% of these patients experienced a breakthrough seizure within 5 years. A retrospective single centre cohort of 187 medically refractory epilepsy patients was followed for a mean of almost 6 years (48, 49). Using Kaplan­ Meier analysis, the investigators found the probability of attaining 1-year seizure remission to be 3­4% per year. However, of those achieving remission, the cumulative probability of seizure relapse was 81%. A population-based cohort of 128 children who failed two drugs was prospectively followed for at least 1 year (50). However, of the 124 children followed for 3 years, only 28 (23%) achieved a greater than 3-year remission rate at last contact, leading the authors to conclude that remission after two-drug failure in children was common but often temporary. The overall data for seizure control in medically refractory epilepsy demonstrate the chances for seizure remission to be low, with the added unfortunate factor of a fairly high relapse rate. The age of onset is usually before age 8 with a peak age of onset between 3­5 years of age. The aetiology can be symptomatic or cryptogenic, and is often a sequelae of infants diagnosed with infantile spasms or West syndrome. Most patients report an aura, which consists of an epigastric sensation (a rising sensation, butterflies, nausea), fear, olfactory hallucinations, lightheadedness, or déjà vu (41). In a large hospital-based survey of over 2200 adult patients with varying Prognostic factors for seizure remission Different studies have used different methodologies, and prognostic factors which were analysed varied between studies, making strong conclusions untenable. In addition, there are only a few papers with multivariate analysis, and the potential interaction between prognostic factors is not well studied. Nevertheless, a few consistent factors emerge for both positive and negative prognosis for seizure remission. As shown earlier in this chapter, continued seizure activity after adequate trials of two to three first-line anticonvulsant drugs portends a lower possibility of sustained seizure remission. In addition, the duration of active seizure activity is inversely correlated to the chances of becoming seizure free. Conclusion the prognosis for persons with epilepsy to enter remission is generally favourable. Data from resource-poor countries indicate that even some untreated or undertreated patients will spontaneously become seizure free. With appropriate treatment, about two-thirds of people will achieve seizure remission. Clearly, there is a minority of epilepsy patients who become medically refractory, and currently are unlikely to achieve any prolonged period of seizure remission. It is for this population of patients that newer treatment options can make the most dramatic impact. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Remission of seizures in a population-based adult cohort with a newly diagnosed unprovoked epileptic seizure. Longterm prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Natural history and mortality of chronic epilepsy in an untreated population of rural Bolivia: a follow-up after 10 years. Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. Outcome of childhood epilepsy: a population-based study with a simple predictive 24. Surgical outcome of patients with mesial temporal lobe epilepsy related to hippocampal sclerosis. Callaghan B, Schlesinger M, Rodemer W, Pollard J, Hesdorffer D, Allen Hauser W, et al. Remission and relapse in a drug-resistant epilepsy population followed prospectively. Seizure remission in adults with long-standing intractable epilepsy: an extended follow-up. The benefit of active drug trials is dependent on aetiology in refractory focal epilepsy. Prognostic significance of interictal epileptiform discharges in newly diagnosed seizure disorders. This chapter will review those interactions that are most frequently encountered clinically and those interactions which because of their magnitude are particularly likely to result in adverse clinical consequences. Mechanisms of drug interactions There are two types of interaction, pharmacokinetic interactions and pharmacodynamic interactions. Induction or inhibition of drug metabolizing enzymes are the principal mechanisms of these interactions whilst pharmacokinetic interactions at the level of absorption, protein binding, and excretion are rare.

Purchase genuine lopinavir. Don't Let Me Go (투명 우산) - SHINee (샤이니) [HAN/ROM/ENG COLOR CODED LYRICS].

In addition to levetiracetam medications vaginal dryness 250 mg lopinavir order amex, there are also data from open studies in support of oxcarbazepine (86) and topiramate (87) symptoms cervical cancer lopinavir 250 mg buy otc. Such toxicity may be even more problematic in the presence of comorbid conditions affecting balance schedule 6 medications discount lopinavir 250 mg, coexistent dementia symptoms influenza lopinavir 250 mg discount, or previous cerebrovascular disease medicine cabinets with mirrors purchase lopinavir master card. In addition, unpleasant sedation is another side effect, which may be exacerbated in patients already on psychoactive drugs. In one study, 25% of older patients with epilepsy were taking 15 or more drugs (mean of seven) (43). First, they raise the obvious issue of drug interactions, which one must consider prior to commencing patients on anticonvulsant therapy. Second, the need to administer multiple medications on a daily basis can very easily result in the omission of medications, uncertainty regarding their necessity, and confusion regarding the dosing regimes. Such potential problems with adherence are further amplified by the cognitive decline and visual impairment that are more prevalent amongst this cohort. Overall, therefore, we advocate starting patients on single agents with as simplified a regimen as possible. To summarize, valproate, lamotrigine, levetiracetam, or pregabalin are useful as initial anticonvulsant therapy, as these drugs have the least potential for interaction with commonly used medications and are largely well tolerated. Lamotrigine has the strongest evidence in support of its use in the elderly, and should be titrated slowly to a target dose of 100 mg/day. An alternative is lower-dose oxcarbazepine if cerebrovascular risk management with warfarin is not anticipated. Zonisamide and topiramate also have relatively few drug­drug interactions, but are more likely to produce cognitive side effects and increase the risk of nephrolithiasis. Multiple interactions Caution: conduction defects Pragmatic dosing: 200 mg/day 230 mg/day 260 mg/day Advantages: gold standard for generalized seizures. Enzyme inhibition Pragmatic dosing: 200 mg bd 400 mg bd Advantages: therapeutic efficacy at starting dose. Weak effect Caution: dose adjust with renal failure Pragmatic dosing: 400 mg bd 400 mg tds 600 mg tds 800 mg tds Advantages: broad spectrum. Notable: sedation early, neurobehavioural Advantages: therapeutic efficacy at starting doses. No interactions Disadvantages: irritability, sedation at onset, mood disturbance uncommon but can be profound Pragmatic dosing: 250 mg bd 500 mg bd (monthly increments) Advantages: well tolerated. Disadvantages: few data in elderly Pragmatic dosing: 75mg bd 150 mg bd (monthly increments) Advantages: broad spectrum Disadvantages: slow titration. Notable: cognitive, nephrolithiasis, word-finding difficulties (weak carbonic anhydrase inhibitor) Other: headache, fatigue, dizziness, paraesthesiae, affect, gait/ataxia, weight loss Generally well-tolerated. Notable: cognitive and behavioural, rash, sedation, nephrolithiasis (weak carbonic anhydrase inhibitor). Target dose: 25 mg bd 50 mg bd 75 mg bd 100 mg bd (monthly to bimonthly increments) epilepsy in the elderly bd, twice a day. There is significant potential for social isolation caused by falls, confusion, and amnesia, which can be further enhanced by the driving restrictions that are imposed following a seizure. Furthermore, there is a higher prevalence of depression, anxiety, and poor sleep compared to age-matched controls (96), which may be worsened by the stigma towards the disease. Together, these issues have the potential to contribute to a poorer overall quality of life, and the physician needs to be vigilant to advocate for independence with spouses, family, and regulating bodies. Antipsychotics Benzodiazepines Cardiovascular Conclusions Overall, the care of the elderly patient with epilepsy poses special challenges to the modern neurologist. Similar to other age groups, the cornerstone of management remains diagnostic rigor, especially as seizures present commonly, and sometimes atypically, in this population. Comorbidities, including cerebrovascular risk factors and cognitive impairment should be sought, as the impact of treatment should not risk overall morbidity and mortality. Immunosuppressants Cyclosporine, sirolimus, tacrolimus Steroids Miscellaneous Other management issues In addition to the epilepsy itself, bone health is an important management issue. In the elderly, not only is the incidence of osteoporosis increased, but lack of exercise, inadequate nutrition, and poor mobility can contribute to impaired balance. It is therefore critical to monitor elderly patients for the development of such side effects, and to reduce the dose to the minimum. It is also worth recalling the association between seizures and stroke as described earlier. Because late-onset seizures are a predictor of subsequent stroke (91), those who have their first unprovoked seizure above age 60 should have their vascular risk evaluated, and their risk factors managed appropriately. In the two-thirds in whom no aetiology is found, it is prudent to remain vigilant and monitor for the possibility of seizures as the sentinel event of an emerging neurodegenerative disorder. Finally, for those patients who have had a severe traumatic brain injury (92) or cerebral neoplasm (93), there is no evidence for long-term seizure prophylaxis with anticonvulsant therapy. Antiepileptic drug use and epileptic seizures in elderly nursing home residents: a survey in the province of Pavia, Northern Italy. The prevalence and demographic distribution of treated epilepsy: A community-based study in Tasmania, Australia. Few studies have been conducted on the impact of epilepsy on the morbidity of elderly patients. The incidence of epilepsy and unprovoked seizures in multiethnic, urban health maintenance organizations. A prospective population-based epidemiologic study of status epilepticus in Richmond Virginia. Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. A survey of epileptic disorders in southwest France: seizures in elderly patients. Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice. Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. The use of computer-assisted-telephone-interviewing to diagnose seizures, epilepsy and idiopathic generalized epilepsy. Acute confusion or altered mental state: consider nonconvulsive status epilepticus. Surgical treatment for refractory temporal lobe epilepsy in the elderly: seizure outcome and neuropsychological sequels compared with a younger cohort. The current state of knowledge on age, sex, and their interactions on clinical pharmacology. An international multicenter randomised double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy. New onset geriatric epilepsy: a randomised study of gabapentin, lamotrigine and carbamazepine. The use of levetiracetam in monotherapy in post stroke seizures in the elderly population. Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study. Cognitive effects of anticonvulsant monotherapy in elderly patients: a placebo-controlled study. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumours: report of the Quality Standards Subcommittee of the American Academy of Neurology. Depression occurs in about 30%, anxiety disorders in 10­25%, and psychosis in 2­7% (1). However, such comorbidity frequently goes unrecognized and untreated while it should represent a major concern in the assessment of patients with epilepsy, as there are important reciprocal interactions between the disorders, not only in their clinical manifestations, but also in the effects of their treatments. The first step in the management of these patients should be an attempt to analyse and identify the various elements that may contribute to psychiatric symptoms, such as psychosocial issues, adverse treatment effects, or neurobiological factors directly related to the seizures or the epileptic disorder. Patients with epilepsy may experience a number of psychiatric manifestations around the ictus that have to be clearly differentiated from true psychiatric comorbidities. The practicality of classifying such symptoms according to their temporal relation to seizure occurrence (peri-ictal/paraictal symptoms vs. Peri-ictal phenomena have been well described by Gowers (4) and Jackson (5) but also by Kraepelin (6) and Bleuler (7). The differentiation between peri-ictal and interictal psychiatric symptoms has relevant implications in terms of prognosis and treatment. In this chapter, major psychiatric syndromes are discussed in the context of the management of epilepsy. Peri-ictal mood and anxiety symptoms Around one-third of patients with partial seizures report premonitory symptoms, usually before secondary generalized tonic­clonic seizures (1). Prodromal moods of depression or irritability may occur hours to days before a seizure and are often relieved by the convulsion (15). Among pre-ictal symptoms, behavioural changes are those most frequently reported (16). In our case series, around 13% of patients experience irritability, dysphoria, or depressed mood preceding seizures (17). Such feelings are almost indistinguishable from interictal ones, apart from duration and close relation with seizure occurrence. It seems, therefore, important for clinicians to enquire about these phenomena, because they cannot be detected by rating scales or questionnaires (18). Ictal fear or ictal panic is the most frequently reported ictal psychiatric manifestation and it usually represents a partial seizure originating in right mesial temporal lobe structures (19). It seems to be reported by 10­15% patients with partial seizures (1), is more common in women than men (20, 21), and seems to have a poor prognostic value for surgery (22). Ictal depression is the second most frequently reported ictal psychiatric manifestation. Such mood changes include anhedonia, feelings of guilt and intense suicidal ideation. Mood and anxiety disorders Mood and anxiety disorders represent the most frequent psychiatric comorbidity in patients with epilepsy and reasons for such a close link are both biological and psychosocial (8). On the one hand, epilepsy is a chronic disorder that brings about a number of social limitations. On the other hand, the biological contri bution to this association is given by neuroanatomical and Table 19. A case series in a monitoring unit reported 18% of patients having at least five symptoms of depression lasting more than 24 hours (23). A comparison of seizure-related variables between these subjects and patients without any postictal psychiatric symptom failed to reveal any differences, although patients with postictal depression seem to be more likely to have a previous history of psychiatric disorders (24). Manic/hypomanic symptoms are reported postictally in 22% of patients, often with associated psychotic phenomenology (23). It seems that postictal mania has a distinct position among psychiatric manifestations observed in the postictal period. In about 33% of cases postictal anxiety is reported by patients with a previous history of an anxiety disorder. However, it is equally reasonable to assume that the underlying brain pathology can influence the expression of mood disorder symptoms making less evident some aspects or emphasizing others. Pre-modern psychiatrists, such as Kraepelin and Bleuler, observed that patients with epilepsy may develop a pleomorphic pattern of depressive symptoms intermixed with euphoric moods, irritability, fear, and anxiety as well as anergia, pain and insomnia (42, 43). Studies of our group pointed out that such a condition is a mood disorder probably not specific of epilepsy, being diagnosed also in patients with migraine, which is usually diagnosed during the depressive phase with a significant comorbid anxiety (social phobia and/or generalized anxiety disorder) and a relevant component of mood instability (45). On one hand, it emphasizes the need to dissect out peri-ictal manifestations from interictal ones being the former related to the prognosis and treatment of the epileptic syndrome. Interictal depressive and anxiety disorders Data from community-based studies report prevalence rates for depressive disorders in the order of 20­22% (26, 27). In selected populations, such as tertiary referral centres or surgery programmes, the prevalence is even higher and ranges between 30­50% (28, 29). Such differences partially reflect the severity of the seizure disorder; in fact depression seems to occur in only 4% of seizure-free patients (30). Data on anxiety disorders are limited mainly because they are commonly comorbid with mood disorders but they are believed to have prevalence rates comparable to those of depression. An interesting point, coming from epidemiological data, relates to the observation that the relationship between epilepsy and depression is not necessarily unidirectional, namely that some patients may present a mood disorder before the emergence of the seizure disorder (31). The issue of phenomenology of depression has been matter of debate having a number of implications in terms of diagnosis, treatment and prognosis. In general terms, the psychopathological spectrum of depression in epilepsy is likely to be large. On one hand, it is reasonable to hypothesize that patients with epilepsy can experience forms of mood disorders identical to those of patients without Psychoses Psychoses and thought disorders are relatively rare in patients with epilepsy but represent serious complications affecting prognosis, morbidity, and mortality. Epidemiological evidence pointed out that the incidence of non-organic, non-affective psychoses, including schizophrenia and related disorders, is generally overrepresented (around 4­5%) in epilepsy as compared to the general population or other chronic medical conditions (46, 47). Higher prevalence rates have been found in selected samples such as hospital case series (48, 49). Interestingly, a family history of psychoses and a family history of epilepsy seem to be significant risk factors for psychosis suggesting strong neurobiological underpinnings between the two disorders (47). Peri-ictal psychotic symptoms the so-called ictal psychosis usually represents a complex partial status of temporal lobe origin and less frequently an extratemporal partial status. Very rarely it has been reported as the manifestation of an absence status but studies are lacking. Simple focal status or aura continua may determine complex hallucinations resembling a thought disorder but insight is usually maintained making the differential diagnosis quite straightforward. Among peri-ictal psychoses, postictal ones represent the most common type, accounting for approximately 25% of psychoses of epilepsy. They are usually precipitated by a series of secondary generalized tonic­clonic seizures (51, 52). Essentially, they seem to occur with later age of onset of epilepsy and at a later age than interictal psychoses. Failure to appreciate the presence of this lucid interval can lead to a misdiagnosis of this condition.

Diseases

• Alopecia macular degeneration growth retardation
• Fukuda Miyanomae Nakata syndrome
• Sensory processing disorder
• Lethal chondrodysplasia Seller type
• Mental retardation progressive spasticity
• Hip dysplasia (canine)
• Malignant hyperthermia susceptibility type 4

References

• Hurtado, F., Gutierrez, J., Castano-Tostado, E. et al. In-vivo relation between CT attenuation value and shockwave fragmentation. J Endourol 2007;21:343-346.
• Athmann C, Zeng N, Scott DR, Sachs G: Regulation of parietal cell calcium signaling in gastric glands. Am J Physiol 279:G1048, 2000.
• Saunier S, Clado J, Helig K, et al: A novel gene that encodes a protein with a putative src homology 3 domain is a candidate gene for familial juvenile nephronophthisis, Hum Mol Genet 17:2317n2323, 1997.
• Horne MK III, Chang R. Thrombosis related to venous access devices. In Kitchens C, Alving B, Kessler C, eds. Consultative Hemostasis and Thrombosis. 2nd ed. Philadelphia, PA: W. B. Saunders; 2007:553-559.
• Jones LW, Hornsby WE, Freedland SJ, et al: Effects of nonlinear aerobic training on erectile dysfunction and cardiovascular function following radical prostatectomy for clinically localized prostate cancer, Eur Urol 65:852n855, 2014.